Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, a (Q44907391)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, a |
scientific article |
Statements
1 reference
Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, a (English)
1 reference
Paul Dent
1 reference
Mohamed Rahmani
1 reference
Erin Reese
1 reference
Yun Dai
1 reference
Cheryl Bauer
1 reference
Lora B Kramer
1 reference
Mei Huang
1 reference
Richard Jove
1 reference
Steven Grant
1 reference
29 December 2004
1 reference
1 reference
Identifiers
1 reference